China Animal Husbandry Industry Co., Ltd., together with its subsidiaries, engages in research, development, production, sales, and technical services of animal health and nutrition products in China and internationally. It operates through four segments: Animal Disease Epidemic Prevention; Animal disease treatment; Animal Nutrition; and Others. The company offers veterinary biological products, such as poultry, livestock, and pet vaccines; biological products, including pathogenic avian influenza vaccines; veterinary chemical products which includes tylosin, tivamisins, florfenicol raw materials, mulex, fluoxetine, sulfachlorpyridazine sodium, and pet disinfectants; feed and feed additive products consist of compound vitamins and compound premixes under the Hualuo brand; trade of feed raw materials; and feed additives, such as corn and corn by-products, soybean and fish meal, and lysine. It also provides veterinary vaccines and drug products; and animal nutrition products. China Animal Husbandry Industry Co., Ltd. was founded in 1998 and is headquartered in Beijing, China.
Research context
China Animal Husbandry Industry Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
China Animal Husbandry Industry Co., Ltd is currently in a long term downtrend where the price is trading 10.0% below its 200 day moving average.
From a valuation standpoint, the stock is 74.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.5.
China Animal Husbandry Industry Co., Ltd's total revenue rose by 17.7% to $1B since the same quarter in the previous year.
Its net income has dropped by 302.5% to $-66M since the same quarter in the previous year.
Finally, its free cash flow grew by 90.3% to $313M since the same quarter in the previous year.
Based on the above factors, China Animal Husbandry Industry Co., Ltd gets an overall score of 3/5.